Reigster Button v3

Confirmed International Speakers

Stephen 150x150

Dr Stephen Kingsmore - President and CEO at Rady Children’s Institute for Genomic Medicine, USA

Stephen F. Kingsmore is President and CEO of Rady Children’s Institute for Genomic Medicine at Rady Children’s Hospital, San Diego, which is implementing pediatric genomic/precision medicine at unprecedented scale.

Previously he was the Dee Lyons/Missouri Endowed Chair in Genomic Medicine at the University of Missouri-Kansas City School of Medicine and Director of the Center for Pediatric Genomic Medicine at Children’s Mercy Hospital, Kansas City. He has been the President and CEO of the National Center for Genome Resources, Santa Fe, New Mexico, Chief Operating Officer of Molecular Staging Inc., Vice President of Research at CuraGen Corporation, founder of GatorGen, and Assistant Professor at the University of Florida’s School of Medicine.

Dr. Kingsmore received MB ChB BAO and DSc degrees from the Queen’s University of Belfast. He trained in clinical immunology in Northern Ireland and did residency in internal medicine and fellowship at Duke University Medical Center. He is a fellow of the Royal College of Pathologists.

He was a MedScape Physician of the year in 2012, and received the 2013 Scripps Genomic Medicine award and 2013 ILCHUN prize of the Korean Society for Biochemistry and Molecular Biology. TIME magazine ranked his rapid genome diagnosis one of the top 10 medical breakthroughs of 2012. In March of 2015, Dr. Kingsmore surpassed his previous record in genetic sequencing by reducing the process to 26 hours which was recognized in April 2016 by Guinness World Record as the fastest genetic sequencing in the world

Richard Scott

Dr Richard Scott - Clinical Lead for Rare Disease Genomics England, UK

Richard Scott is Clinical Lead for Rare Disease for the 100,000 Genomes Project at Genomics England and a Consultant and Honorary Senior Lecturer in Clinical Genetics at Great Ormond Street Hospital for Children and the UCL Institute of Child Health. Dr Richard Scott - Clinical Lead for Rare Disease at Genomics England, UK

Richard trained in medicine at Cambridge University and University College London. He specialised in Paediatrics and subsequently Clinical Genetics in London and completed his PhD on childhood cancer syndromes at the Institute of Cancer Research. His main interests are in the clinical and molecular diagnosis of rare dysmorphic, neurological and multisystem childhood disorders. He has a particular interest in the translation of new genetic technology into clinical practice.

Separating Line thin

Confirmed National Speakers

A/Prof Gareth Baynam
Director, Undiagnosed Diseases Program, Western Australia
Head, Western Australian Register of Developmental Anomalies

Prof Hamish Scott
Head, Department of Genetics and Molecular Pathology
Director, Centre of Cancer Biology ACRF Cancer Genome Facility at SA Pathology

Dr Jodie Ingles
Head, Clinical Cardiac Genetics Group, Molecular Cardiology Program, Centenary Institute

Prof Deborah Schofield
Chair and Professor of Health Economics, Faculty of Pharmacy

Prof John Christodoulou
Chair of Genomic Medicine, Dept of Paediatrics, University of Melbourne

A/Prof Edwin Kirk
Genetic Pathologist, SEALS Genetics, NSW Health Pathology

Dr Mark Cowley
Team Leader of Translational Genomics, Garvan Institute of Medical Research

A/Prof Kristine Barlow-Stewart
Director, Master of Genetic Counselling Program, University of Sydney

Prof John Mattick
CEO, Garvan Institute of Medical Research

A/Prof Marcel Dinger 
CEO, Genome.One
Head, Kinghorn Centre for Clinical Genomics

Dr Yemina Berman
Head, Clinical Genetics Service RNSH

Dr Zornitza Stark 
Clinical Geneticist, ‎Victorian Clinical Genetics Services

A/Prof Clara Gaff
Executive Director, Melbourne Genomics Health Alliance

A/Prof Julie McGaughran 
Director, Genetic Health Queensland

Dr Hugh McCarthy
Paediatric Nephrologist, Sydney Children's Hospital Network

Prof Carolyn Sue
Director of Neurogenetics, Royal North Shore Hospital 

Dr Alison Colley
Director, Clinical Genetics at Liverpool Hospital

Prof David Thomas
Director, The Kinghorn Cancer Centre
Division Head, Cancer Division of the Garvan Institute of Medical Research